Diego Miralles, MD, PhD
CEO, Vividion Therapeutics
Diego comes from an extensive background in leading and developing innovative businesses. He was previously President of Adaptive Therapeutics, where he built a therapeutics program leveraging Adaptive immunosequencing platform. He had an extensive career at Johnson & Johnson, which he joined in 2005 as VP of Clinical Development at Tibotec in Belgium where he was involved in the development and approval of PREZISTA® and INTELENCE®, among several other drugs in the portfolio. In 2008, he moved back to the US to head the Janssen Research and Early Development unit in La Jolla, CA.
While at Johnson & Johnson, he founded and launched the JLABS incubator in 2012 for start-up life science entrepreneurs, a model that has been replicated in six locations across North America, and was instrumental in developing and launching Johnson & Johnson’s Innovation center model in 2013. Additionally, he established Janssen Healthcare Innovation in 2011. Through his external networking activities, he contributed significantly to Johnson & Johnson’s growing reputation as an innovative healthcare company.
Prior to Johnson & Johnson, Diego held R&D positions at Trimeris and Triangle Pharmaceuticals and was an Assistant Professor at Duke University Medical Center, where he was a bench scientist and an Infectious Disease physician, with a focus on HIV. He is currently an Adjunct Professor in the Department of Pharmacology at the University of California San Diego. He received his MD degree from the Universidad de Buenos Aires, Argentina. He completed his internal medicine residency at the Mayo Clinic and was a fellow in Infectious Diseases at Cornell University-New York Hospital.
Diego has a strong passion for advancing healthcare innovation on behalf of patients.